| abstract |
A method of treating steroid-responsive skin disease in mammals, including humans in need of treatment, comprising N-{(1S) -2-amino-1-[(3-fluorophenyl) methyl to the mammal ] Ethyl} -5-chloro-4- (4-chloro-1-methyl-1H-pyrazol-5-yl) -2-thiophenecarboxamide or a pharmaceutically acceptable salt thereof, and the compound N-{(1S) -2-amino-1-[(3,4-difluorophenyl) methyl] ethyl} -5-chloro-4- (4-chloro-1-methyl-1H-pyrazol-5-yl) -2-furancarboxamide or A method has been invented comprising the administration of a therapeutically effective amount of a compound selected from the group consisting of its pharmaceutically acceptable salts. |